MARSHALL WACE, LLP

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1318757 LONDON, X0

Position in ORMP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$490,393

-$392,284 QoQ

Shares Held

101,953

-60.7% QoQ

Ownership

0.245%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 84 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ORMP ranks #215 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$490,393	101,953	-60.7%	Shares	Other	2026-08-13
2026-03-31	$882,677	259,611	+0.2%	Shares	Other	2026-05-15
2025-12-31	$738,306	259,055	+1050.0%	Shares	Other	2026-02-13
2024-09-30	$54,965	22,527	+113.5%	Shares	Other	2024-11-14
2023-03-31	$23,005	10,553	-71.8%	Shares	Other	2023-05-15
2022-12-31	$449,909	37,399	+31.6%	Shares	Other	2023-02-14
2022-09-30	$184,090	28,409	+45.6%	Shares	Other	2022-11-14
2022-06-30	$89,351	19,509	+68.7%	Shares	Other	2022-08-15
2021-03-31	$117,480	11,563	-68.4%	Shares	Sole	2021-05-17
2020-12-31	$155,319	36,632	-37.5%	Shares	Sole	2021-02-16
2020-09-30	$153,071	58,648	+21.5%	Shares	Sole	2020-11-16
2020-06-30	$170,357	48,260	-37.6%	Shares	Sole	2020-08-13
2020-03-31	$235,177	77,361	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.